National Bank of Canada’s Ginkgo Bioworks DNA Stock Holding History

National Bank of Canada’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-225	Closed	-$1.52M	–	2744
2022 Q4	$1.52M	Buy	+225	New	+$20.7K	﹤0.01%	947
2022 Q3	–	Sell	-111	Closed	-$1.05M	–	2732
2022 Q2	$1.05M	Sell	111 -143	-56%	-$17.4K	﹤0.01%	1004
2022 Q1	$4.09M	Buy	254 +70	+38%	+$13.6K	0.01%	680
2021 Q4	$8.42M	Buy	+184	New	+$87.4K	0.03%	427

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

National Bank of Canada's DNA Position: Q2 2026 in Review

National Bank of Canada reduced its Ginkgo Bioworks (DNA) stake by 4.3% in Q2 2026, selling an estimated $100 and leaving 264 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

National Bank of Canada first reported a position in DNA in Q4 2021 and has held it in 16 quarters since. The position peaked at $5.56M in Q2 2025. 73 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

National Bank of Canada held 264 shares of Ginkgo Bioworks worth $2.61K as of Q2 2026.
National Bank of Canada sold 12 Ginkgo Bioworks shares in Q2 2026, an estimated $100.
Ginkgo Bioworks made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2674 holding.
National Bank of Canada first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 16 quarters since.
National Bank of Canada's Ginkgo Bioworks position peaked at $5.56M in Q2 2025.
73 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.